| 中文名 | 替诺福韦艾拉酚胺半富马酸盐 |
|---|---|
| 英文名 | Tenofovir Alafenamide Hemifumarate |
| 中文别名 |
富马酸磷丙替诺福韦(替诺福艾拉盼胺)
泰诺福韦艾拉酚胺富马酸(2:1) 富马酸丙酚替诺福韦, 替诺福韦艾拉酚胺富马酸盐, Tenofovir alafenamide fumate (TAF) 替诺福韦-阿拉芬酰胺半富马酸盐[USAN 诺福韦艾拉酚胺半富马酸盐 替诺福韦艾拉酚胺富马酸盐(TAF) 丙酚替诺福韦原料药 替诺福韦艾拉酚胺中间体1392-7 富马酸泰诺福韦艾拉酚胺 富马酸磷丙替诺福韦(替诺福韦艾拉酚胺) 富马酸丙酚替诺福韦(TAF) 替诺福韦艾拉酚氨半富马酸 泰诺福韦艾拉酚胺半富马酸盐 泰诺福韦二吡呋酯富马酸 替诺福韦艾拉酚胺半富马酸 富马酸丙酚替诺福韦 富马酸磷丙替诺福韦 半富马酸盐GS7340 替诺福韦艾拉芬胺 GS-7340半富马酸盐 富马酸丙酚替诺福韦 (富马酸替诺福韦艾拉酚胺) 富马酸丙分替诺福韦 替诺福韦艾拉酚胺版富马酸盐 替诺福韦-阿拉芬胺半富马酸盐[USAN] 富马酸丙芬替诺福韦 (S)-丙胺酸异丙酯2-{(S)-[((R)-1-(6-氨基-9H-嘌呤-9-基)-1-甲基乙氧基]甲基}-苯氧基磷酰基半反丁烯二酸盐 替诺福韦艾拉酚胺富马酸盐(2:1) 富马酸丙酚替诺佛韦 GS-7340 (HEMIFUMATE)|||TENOFOVIR ALAFENAMIDE FUMATE|||替诺福韦艾拉酚胺富马酸盐 替诺福韦-富马酸阿芬烯胺[ USAN ] 富马酸替诺福韦艾拉芬胺 替诺福韦艾拉芬胺半富马酸 替诺福韦艾拉酚胺富马酸半盐 泰诺福韦艾拉酚胺富马酸(2:1) CRS 替诺福韦艾拉芬胺半富马酸盐 (((((R)-1-(6-氨基-9H-嘌呤-9-基)丙烷-2-基)氧基)甲基)(苯氧基)磷酰基)-L-丙氨酸异丙基 半富马酸盐 替诺福韦艾拉酚胺富马酸 L-丙氨酸,N-[(S)-[[(1R)-2-(6-氨基-9H-嘌呤-9基)-1-甲基乙氧基]甲基]苯氧基氧膦基],1-甲基乙基酯,(2E)丁烯二酸(2:1) 泰诺福韦艾拉酚胺富马酸 替诺福韦ALAFENAMIDE富马酸酯 N-[(S)-[[(1R)-2-(6-氨基-9H-嘌呤-9-基)-1-甲基乙氧基]甲基]苯氧基氧膦基]-L-丙氨酸异丙酯半富马酸盐 |
| 英文别名 |
Anti-HIV
Isopropyl N-[(S)-({[(2R)-1-(6-amino-9H-purin-9-yl)-2-propanyl]oxy}methyl)(phenoxy)phosphoryl]-L-alaninate (2E)-2-butenedioate (2:1) GS-7340 Hemifumarate TAF(Tenofovir Alafenamide Hemifumate) 3H-1,2,4-Triazole-3-thione,4-amino-2,4-dihydro-5-(10-methoxyphenyl) Tenofovir Alafenamide Hemifumate salt Tenofovir Alafenamide Hemifumate(2:1) TENOFOVIR ALAFENAMIDE HEMIFUMATE (GS-7340 HEMIFUMATE) Tenofovir alafenamide hemifumate (GS-7340) L-Alanine, N-[(S)-[(1S)-[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-, 1-methylethyl ester, (2E)-2-butenedioate (2:1) enofovir Alafenamide Fumarate (R)-isopropyl 2-(((S)-((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)amino)propanoate fumate Tenofovir Alafenamide Fumate //BP (Tenofovir alafenamide : fumate = 2:1) GS-7340 (hemifumate) Tenofovir alafenamide fumarate, 2:1 L-Alanine,N-((S)-(((1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy)methyl)phenoxyphosphinyl)-,1-methylethyl ester,(2E)-2-butenedioate (2:1) Tenofovir Alafenamide fumate (E)-but-2-enedioic acid,propan-2-yl (2S)-2-[[1-(6-aminopurin-9-yl)propan-2-yloxymethyl-phenoxyphosphoryl]amino]propanoate Tenofovir Alafenamide Fumate API 1-Methylethyl N-((S)-(((1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy)methyl)phenoxyphosphinoyl)-L-alaninate Tenofovir Alafenamid Tenofovir Alafenamide fumate [USAN] Tenofovir Alafenamide fumateQ: What is Tenofovir Alafenamide fumate Q: What is the CAS Number of Tenofovir Alafenamide fumate GS-7340-03 Tenofovir alafenamide hemifumate GS7340(Tenofovir Alafenamide Fumate) 1-Methylethyl N-((S)-(((1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy)methyl)phenoxyphosphinoyl)-L-alaninate,(2E)-2-butenedioate Tenofovir Alafenamide Hemifumate(2:1) CRS (S)-isopropyl 2-(((S)-((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)amino)propanoate hemifumate Tenofovir levamide amine fumate Tenofovir alafenamide fumarate Celiprolol Impurity 8(Celiprolol Impurity H) (S)-Isopropyl 2-(((S)-((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)amino)propanoate fumate(2:1) L-Alanine,N-[(S)-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-, 1-methylethyl ester, (2E)-2-butenedioate (2:1) Isopropyl (((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)-L-alaninate hemifumate 2-fluoro-5-[(4' -0x'H-phthalazin-1'-yl)methyllbenzoic acide' API-Anti-HBV Tenofovir alafenamide hemifumate, 10 mM in DMSO Phosphonoformic Acid Fumate N-[(S)-[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-L-alanine 1-methylethyl ester (2E)-2-butenedioate (2:1) Tenofovir dipivoxil phenol amine fumate N-[(S)-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-, 1-methylethyl ester GS-7340 (hemifumarate) Tenofovir Alafenamide Hemifumate salt[USAN GS-7340 (hemifumate)|||Tenofovir alafenamide fumate Alafenamide hemifumate |
| 描述 | Tenofovir alafenamide hemifumarate (GS-7340 hemifumarate) 是 Tenofovir 的前体,Tenofovir 是一种 HIV-1 核苷酸逆转录酶抑制剂。 |
|---|---|
| 相关类别 | |
| 靶点 |
HIV-1, NRTIs[1] |
| 体外研究 | 所有细胞类型的替诺福韦艾拉酚胺(GS-7340)抗病毒活性相似,范围为5至7 nM,而MT-4和MT-2细胞的CC50分别为4.7至42μM。针对一组HIV-1和HIV-2分离株评估TAF的抗病毒活性,包括HIV-1组M亚型A至G,以及N和O组分离株。总体而言,对于在PBMC中测试的29种初级HIV-1分离株,TAF EC50的范围为0.1至12nM,平均EC50为3.5nM,而AZT的平均EC50为11.8nM,其用作内部对照。对于HIV-2分离株,TAF的平均EC50为1.8 nM,AZT的平均EC50为6.4 nM [2]。 |
| 体内研究 | 替诺福韦艾拉酚胺(GS-7340)是替诺福韦的酰胺类前药,与替诺福韦地索普西富马酸盐(TDF)相比具有良好的口服生物利用度并增加血浆稳定性[1]。 |
| 参考文献 |
| 分子式 | C46H62N12O14P2 |
|---|---|
| 分子量 | 1069.0 |
| 精确质量 | 1068.39836869 |
| PSA | 381.18000 |
| LogP | 7.60180 |
| 储存条件 | 2-8°C |
| 危害码 (欧洲) | Xi |
|---|